BiomX (PHGE) Construction in Progress (2024)
BiomX's (PHGE) quarterly Construction in Progress came in at $15.3 million in Q3 2024.
Powered by 
Analysis
BiomX (PHGE) Construction in Progress (2024) Analysis & Trends
BiomX has disclosed Construction in Progress across 1 years of filings, most recently posting $15.3 million for Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.59 Bn | 193.60 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.73 Bn | 175.55 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.17 Bn | 123.32 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.73 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.01 Bn | 55.82 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.40 Bn | 48.27 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.64 Bn | 30.35 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.66 Bn | 29.66 Bn | 1.16 Mn | - |
| 10 | BiomX | 17.64 Mn | 17.06 Mn | 97,000.00 | - |